Fiona M. Ross

7.3k total citations · 1 hit paper
84 papers, 4.5k citations indexed

About

Fiona M. Ross is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Fiona M. Ross has authored 84 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 33 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Fiona M. Ross's work include Multiple Myeloma Research and Treatments (39 papers), Protein Degradation and Inhibitors (17 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Fiona M. Ross is often cited by papers focused on Multiple Myeloma Research and Treatments (39 papers), Protein Degradation and Inhibitors (17 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Fiona M. Ross collaborates with scholars based in United Kingdom, United States and Italy. Fiona M. Ross's co-authors include Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Brian A. Walker, Graham Jackson, Laura Chiecchio, Mark T. Drayson, Nicholas C.P. Cross, Roger G. Owen and Gordon Cook and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Fiona M. Ross

83 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

2010 807 citations Fiona M. Ross et al. Nature Genetics profile →

Peers

Fiona M. Ross

HEMAT

ONCOL

GENET

PFM

Rafat Abonour United States

C. Michel Zwaan Netherlands

Larry D. Cripe United States

Sue Bell United Kingdom

Mike Scott United Kingdom

Christopher R. Cogle United States

Juan José Lahuerta Spain

Luis Isola United States

J Gäbert France

Christopher B. Miller United States

Rafat Abonour United States

Fiona M. Ross

2.1k ×0.8

2.6k ×1.0

HEMAT

1.9k ×1.5

ONCOL

576 ×0.7

GENET

173 ×0.5

PFM

Citations per year, relative to Fiona M. Ross Fiona M. Ross (= 1×) peers Rafat Abonour

Countries citing papers authored by Fiona M. Ross

Since Specialization

Citations

This map shows the geographic impact of Fiona M. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona M. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona M. Ross more than expected).

Fields of papers citing papers by Fiona M. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona M. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona M. Ross. The network helps show where Fiona M. Ross may publish in the future.

Co-authorship network of co-authors of Fiona M. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona M. Ross. A scholar is included among the top collaborators of Fiona M. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona M. Ross. Fiona M. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walker, Brian A., Christopher P. Wardell, David C. Johnson, et al.. (2013). Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells. Blood. 121(17). 3413–3419. 100 indexed citations

Boyd, Kevin, Fiona M. Ross, Laura Chiecchio, et al.. (2011). Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma. Cancer Epidemiology Biomarkers & Prevention. 20(8). 1703–1707. 33 indexed citations

Wu, Ping, Brian A. Walker, Daniel Brewer, et al.. (2011). A Gene Expression–Based Predictor for Myeloma Patients at High Risk of Developing Bone Disease on Bisphosphonate Treatment. Clinical Cancer Research. 17(19). 6347–6355. 18 indexed citations

Boyd, Kevin, Fiona M. Ross, Brian A. Walker, et al.. (2011). Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival. Clinical Cancer Research. 17(24). 7776–7784. 131 indexed citations

Lee, Diana, et al.. (2011). Informal stroke caregivers’ self‐appraised problem‐solving abilities as a predictor of well‐being and perceived social support. Journal of Clinical Nursing. 21(1-2). 232–242. 18 indexed citations

Boyd, Kevin, Fiona M. Ross, William Tapper, et al.. (2011). The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide‐based therapy. Genes Chromosomes and Cancer. 50(10). 765–774. 50 indexed citations

Morgan, Gareth J., J. Anthony Child, Walter M. Gregory, et al.. (2011). Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. The Lancet Oncology. 12(8). 743–752. 117 indexed citations

Dickens, Nicholas J., Brian A. Walker, Paola Leone, et al.. (2010). Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome. Clinical Cancer Research. 16(6). 1856–1864. 85 indexed citations

Feyler, Sylvia, Sheila J.M. O’Connor, Andy C. Rawstron, et al.. (2008). IgM myeloma: a rare entity characterized by a CD20⁻CD56⁻CD117⁻ immunophenotype and the t(11;14). British Journal of Haematology. 140(5). 547–551. 33 indexed citations

10.

Parker, Helen, Qian An, Kerry E. Barber, et al.. (2008). The complex genomic profile of ETV6‐RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. Genes Chromosomes and Cancer. 47(12). 1118–1125. 43 indexed citations

11.

Smith, E. & Fiona M. Ross. (2007). Service user involvement and integrated care pathways. International Journal of Health Care Quality Assurance. 20(3). 195–214. 17 indexed citations

12.

Ross, Fiona M., et al.. (2006). School nurses' contribution to young people's future health.. PubMed. 101(47). 19–20. 4 indexed citations

13.

Harrison, Christine J., Anthony V. Moorman, Kerry E. Barber, et al.. (2005). Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. British Journal of Haematology. 129(4). 520–530. 92 indexed citations

14.

Illidge, Tim, et al.. (2000). A New in Vivo and in Vitro B cell Lymphoma Model, π-BCL1. Cancer Biotherapy and Radiopharmaceuticals. 15(6). 571–580. 14 indexed citations

15.

Ross, Fiona M., et al.. (2000). Blurring boundaries: professional perspectives of the emergency nurse practitioner role in a major accident and emergency department. Journal of Advanced Nursing. 31(5). 1089–1096. 83 indexed citations

16.

Ross, Fiona M., Martin J. Brodie, & Trevor W. Stone. (1998). Adenosine monophosphate as a mediator of ATP effects at P1 purinoceptors. British Journal of Pharmacology. 124(4). 818–824. 16 indexed citations

17.

Ross, Fiona M. & Peter Bower. (1995). Standardized assessment for elderly people (SAFE) — a feasibility study in district nursing. Journal of Clinical Nursing. 4(5). 303–310. 8 indexed citations

18.

Turner, Gillian, Fiona M. Ross, & A S Krajewski. (1995). Detection of t(14;18) in British follicular lymphoma using cytogenetics, Southern blotting and the polymerase chain reaction. British Journal of Haematology. 89(1). 223–225. 25 indexed citations

19.

Ross, Fiona M., Peter Bower, & Bonnie Sibbald. (1994). Practice nurses: characteristics, workload and training needs.. PubMed. 44(378). 15–8. 62 indexed citations

20.

Brown, Alison G. M., et al.. (1993). Evidence for a new tumour suppressor locus (DBM) in human B–cell neoplasia telomeric to the retinoblastoma gene. Nature Genetics. 3(1). 67–72. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact